Clinical trials
Phase 3 Pancreatic Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vertex Pharmaceuticals Incorporated | 2 |
| Celgene | 1 |
| ChiRhoClin, Inc. | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Rezolute | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| University of Medicine and Dentistry of New Jersey | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Diseases | 8 |
| Digestive System Diseases | 4 |
| Pancreatic Neoplasms | 3 |
| Adenocarcinoma | 2 |
| Cystic Fibrosis | 2 |
| Digestive System Neoplasms | 2 |
| Endocrine Gland Neoplasms | 2 |
| Endocrine System Diseases | 2 |
| Fibrosis | 2 |
| Genetic Diseases, Inborn | 2 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.